Neogenomics Inc (NEO)

Cost of Revenue

$437.40M

TTM · Period ending: · USD

NEO logo

NEO Cost of Revenue

Latest reported$437.40M
NEO TTM Cost of Revenue ($74.29K → $437.40M)
High-resolution chart · PNG

NEO cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Neogenomics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
437,396,000
431,690,000
420,671,000
400,955,000
386,548,000
374,484,000
370,466,000
363,687,000
360,386,000
355,404,000
347,039,000
340,955,000
331,201,000
325,301,000
321,832,000
320,427,000
314,639,000
302,247,000
297,269,000
285,338,000
282,616,000
272,853,000
258,555,000
246,956,000
229,417,000
223,193,000
211,994,000
194,413,000
177,348,000
161,817,000
149,475,000
144,771,000
142,238,000
139,934,000
138,294,000
136,866,000
136,040,000
135,652,000
133,703,000
115,522,000
96,061,000
75,094,000
56,045,000
54,522,000
53,490,000
50,364,000
46,355,000
41,987,000
37,777,000
35,792,000
34,730,000
34,030,000
33,627,000
33,425,000
33,030,000
31,630,000
29,566,000
27,132,000
24,056,000
21,847,000
20,419,000
19,184,000
18,588,000
17,844,000
16,698,000
15,507,000
14,253,000
12,922,000
11,785,000
10,585,000
9,353,000
8,476,000
7,462,000
6,444,000
5,522,734
4,359,445
3,559,311
3,119,127
2,759,190
2,528,187
2,120,497
1,577,072
1,164,889
819,915
639,512
595,495
576,867
563,092
557,737
530,536
481,593
388,830
322,445
282,166
185,123
131,927
70,894
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.